Stockscreener 앱 받기
1.09%
시간 외 거래:
전일 마감가:
$144.42
열려 있는:
$142.61
하루 거래량:
5.54M
Relative Volume:
1.46
시가총액:
$105.29B
수익:
$13.88B
순이익/손실:
$5.40B
주가수익비율:
40.97
EPS:
3.4868
순현금흐름:
$2.02B
1주 성능:
-5.83%
1개월 성능:
-15.20%
6개월 성능:
+3.95%
1년 성능:
-14.48%
1일 변동 폭
$142.45
$145.90
1주일 범위
$142.45
$152.25
52주 변동 폭
$115.66
$200.96
블랙스톤 Stock (BX) Company Profile
명칭
Blackstone Inc
전화
(212) 583-5000
주소
345 PARK AVENUE, NEW YORK, NY
BX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BX
Blackstone Inc
|
142.85 | 113.04B | 13.88B | 5.40B | 2.02B | 3.4868 |
|
BLK
Blackrock Inc
|
1,059.91 | 165.78B | 23.53B | 6.37B | 4.02B | 38.90 |
|
KKR
Kkr Co Inc
|
118.29 | 104.80B | 17.85B | 4.86B | 6.64B | 2.0851 |
|
BAM
Brookfield Asset Management Ltd
|
53.89 | 87.69B | 2.46B | 1.41B | 992.79M | 1.4814 |
|
BN
Brookfield Corporation
|
45.54 | 103.19B | 77.46B | 2.89B | -1.18B | 0.2991 |
블랙스톤 Stock (BX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-03 | 개시 | BMO Capital Markets | Outperform |
| 2025-04-08 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-17 | 업그레이드 | UBS | Neutral → Buy |
| 2024-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-10-09 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-09-12 | 개시 | Wells Fargo | Overweight |
| 2024-08-27 | 개시 | Redburn Atlantic | Neutral |
| 2024-04-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-19 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-01-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-01-04 | 개시 | TD Cowen | Market Perform |
| 2024-01-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-20 | 재개 | Piper Sandler | Overweight |
| 2023-12-06 | 재개 | BMO Capital Markets | Market Perform |
| 2023-10-06 | 개시 | HSBC Securities | Hold |
| 2023-10-05 | 개시 | Wolfe Research | Peer Perform |
| 2023-07-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-05-19 | 개시 | Citigroup | Buy |
| 2023-04-13 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-01-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-12-02 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-11-22 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2022-10-19 | 개시 | Credit Suisse | Neutral |
| 2022-10-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-31 | 개시 | Barclays | Overweight |
| 2022-07-25 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-04-07 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2021-12-16 | 재개 | BofA Securities | Buy |
| 2021-12-16 | 개시 | Wells Fargo | Equal Weight |
| 2021-11-04 | 재개 | BofA Securities | Buy |
| 2021-08-11 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-03-19 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-01-14 | 개시 | Piper Sandler | Overweight |
| 2020-10-29 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-06-25 | 개시 | UBS | Buy |
| 2020-06-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-10-14 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-10-08 | 개시 | BMO Capital Markets | Market Perform |
| 2019-10-01 | 개시 | Wells Fargo | Outperform |
| 2019-09-24 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-09-23 | 재확인 | BofA/Merrill | Buy |
| 2019-09-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-08-05 | 개시 | Barclays | Overweight |
| 2019-07-08 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-01-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2016-03-11 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2016-02-02 | 재확인 | Argus | Buy |
| 2016-01-26 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-01-08 | 재확인 | Deutsche Bank | Buy |
| 2015-12-08 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2015-11-23 | 개시 | JP Morgan | Neutral |
| 2015-10-27 | 재확인 | Argus | Buy |
모두보기
블랙스톤 주식(BX)의 최신 뉴스
SEI gatekeepers drop T. Rowe for Blackstone on $3.2bn high-yield strategy - Citywire
Merck & Co. secures $700M from Blackstone to fund lead ADC sac-TMT - FirstWord Pharma
Merck Entering $700 Million R&D Funding Agreement With Blackstone Life Sciences - Pulse 2.0
Blackstone $1.45bn CMBS oversubscribed - GlobalCapital
Merck & Co Receive $700 Million From Blackstone to Boost Cancer Drug Development - USA Herald
Blackstone Injecting $700M Into Merck Cancer Therapy - Law360
Merck secures $700 million funding from Blackstone to develop cancer therapy - Reuters
Private equity powering AI boom at public cost - Private Equity Stakeholder Project PESP
Merck & Blackstone Enter Research and Development Funding Agreement - Contract Pharma
Blackstone-backed Nexus Select Trust eyes multiple mall acquisitions - livemint.com
Merck strikes financing agreement with Blackstone - MarketScreener
Merck to Receive $700 Million From Blackstone Unit to Support Experimental Cancer Drug Development - MarketScreener
Merck writes tale of 2 checks, bagging $700M from Blackstone and spending $150M to regain asset - Fierce Biotech
Merck (MRK) Secures $700M from Blackstone for Cancer Therapy Dev - GuruFocus
Merck clinches $700 million from Blackstone to develop ADC for cancer - PharmaLive
TriMas Enters Into Agreement to Sell TriMas Aerospace for $1.45 Billion - Business Wire
Merck to receive $700M from Blackstone to develop cancer therapy - MSN
Merck inks $700M deal with Blackstone for cancer drug (MRK) - Seeking Alpha
Blackstone (BX) Invests in Merck's Cancer Treatment Development - GuruFocus
Corton Capital Inc. Invests $327,000 in Blackstone Inc. $BX - MarketBeat
Blackstone to pay Merck $700M to fund development of antibody-drug conjugate - Endpoints News
Wellington Shields Capital Management LLC Grows Stake in Blackstone Inc. $BX - MarketBeat
Royalty Pharma (NASDAQ: RPRX) acquires 1% AMVUTTRA royalty for $310M from Blackstone - Stock Titan
Merck secures $700 million from Blackstone to fund cancer drug development - Investing.com
Blackstone pays Merck $700M to buy into ADC drug royalties - Yahoo Finance
Merck, Blackstone Life Sciences sign R&D funding deal for sacituzumab tirumotecan (sac-TMT) - MarketScreener
Merck and Blackstone enter research agreement to develop cancer therapy for $700 million - MarketScreener
Ex-Blackstone, Partners Group Execs Raise $1.1B for APAC Real Estate Secondaries - Mingtiandi
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT) - MarketScreener
Merck receives $700 million from Blackstone for cancer drug development - StreetInsider
Bank of New York Mellon Corp Sells 288,843 Shares of Blackstone Inc. $BX - MarketBeat
FERC urged to reject Blackstone’s New Mexico utility takeover - Southwest Ledger
Royalty Pharma acquires royalty stake in Alnylam’s Amvuttra from Blackstone for $310m - pehub.com
Blackstone Inc. $BX Shares Sold by Freestone Capital Holdings LLC - MarketBeat
Bank of Montreal Can Lowers Stock Holdings in Blackstone Inc. $BX - MarketBeat
Blackstone’s Gray: We may seek faster exits to avoid AI disruption risk - Private Equity International | PEI
Could Blackstone’s (BX) Moves in Europe and Retirement Markets Redefine Its Competitive Edge? - simplywall.st
Blackstone Mortgage Trust, Inc. (BXMT) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Blackstone VP and Progress Together CEO to address female leaders at FN event - Financial News London
Blackstoneissues $1.2 billion in senior notes due 2030 and 2036SEC filing - MarketScreener
Hologic Tops Expectations And Receives Buyout Offer From Blackstone - Finimize
Blackstone Group Completes $1.2 Billion Senior Notes Offering - TipRanks
Blackstone completes $1.2 billion senior notes offering - Investing.com
Blackstone Completes Senior Notes Offering - The Joplin Globe
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025 - Stock Titan
News | Blackstone secures $1.45 billion CMBS loan for 94-property industrial portfolio - CoStar
Rethinking the 60% - Blackstone
Hedge Fund and Insider Trading News: Scott Bessent, Ray Dalio, Warren Buffett, D.E. Shaw, Davidson Kempner, Millennium Management, Blackstone Inc (BX), Service Corporation International (SCI), and More - Insider Monkey
Blackstone appoints head of CLOs - Pensions & Investments
Leonard Green Is Leading a $1 Billion Ares Continuation Fund - Bloomberg
Blackstone firm launches $3bn Saudi data centre venture - Global Construction Review
블랙스톤 (BX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.56%
0.86%
자본화:
|
볼륨(24시간):